Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, September 8, 2011
Wed, September 7, 2011 
SAN FRANCISCO, Sept. 8, 2011 /CNW/ - Cloud Dx, a division of Biosign Technologies Inc. (TSXV: BIO), a medical device company focused on non-invasive, cloud-based health monitoring, is proud to be the sponsor of the "In Conversation with 3 CEO's" panel at the Health 2.0 Conference.
"In Conversation with 3 CEO's" panel features Anne Wojcicki of 23andme, Sona Mehring of Caring Bridge, and West Shell of Healthline. Cloud Dx, CEO, Dr. Scott Jenkins will introduce the panel and topic to the attendees (expected to exceed 1,000) and speak briefly about the Cloud Dx solution to complete the circle of care utilizing its uFit® technology and remote cloud monitoring systems.
The Health 2.0 Annual Fall Conference is being held in San Francisco at the Hilton, Union Square September 25-27, 2011. Health 2.0 is known for showcasing innovative healthcare technology and bringing together the industry's top thought leaders.
About Biosign Technologies Inc
Biosign Technologies Inc. (TSXV: BIO) provides biomedical systems. Cloud Dx applications include intelligent systems for noninvasive monitoring of common health risks associated with blood pressure, glucose, and medication. Biosign technology combines measurement, analysis, and tools for disease and patient management to support global health monitoring. The uFit® medical device delivers quality data collection and analytics for clinical diagnostics, self-care, wellness, disease state evaluation and management, and remote patient monitoring. For more information visit [ www.biosign.com ].
